Use of minimally modified antisense oligonucleotides for specific inhibition of gene expression.
Uhlmann
E
E
Hoechst Marion Roussel Deutschland GmbH, Frankfurt am Main, Germany.
Peyman
A
A
Ryte
A
A
Schmidt
A
A
Buddecke
E
E
D000818:Animals; D001483:Base Sequence; D001692:Biological Transport; D002460:Cell Line; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D015195:Drug Design; D005786:Gene Expression Regulation / Q000187:drug effects*; D016259:Genes, myc / Q000187:drug effects; D020319:Oligodeoxyribonucleotides, Antisense / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*; D018629:Spectrometry, Mass, Secondary Ion / Q000379:methods; D013329:Structure-Activity Relationship; D013873:Thionucleotides
D020319:Oligodeoxyribonucleotides, Antisense; D013873:Thionucleotides